-
FDA Approvals Summary - July 2025
FDA Drug Approvals
FDA approved several new drugs in July 2025, including treatments for phenylketonuria, chronic hand eczema, hereditary angioedema, EGFR-mutated lung cancer, and relapsed multiple myeloma, offering new hope for patients.
-
First Global DPP1 Inhibitor Approved by FDA
FDA
The FDA has approved brensocatib, the world’s first DPP1 inhibitor, for treating non-cystic fibrosis bronchiectasis in patients aged 12+, marking a breakthrough in targeted respiratory therapies.
-
-
-
-
-
-
-
FDA Puts Gilead’s HIV Combo Trials on Hold
Gilead
The FDA has paused five Gilead HIV combo trials over safety concerns, but the decision does not impact lenacapavir's upcoming PrEP approval. Gilead remains confident in its HIV pipeline and future plans.
-
FDA Narrows Use of PD-1 Drugs in GI Cancers
FDA
The FDA has restricted Merck’s Keytruda and BMS’s Opdivo for use only in PD-L1-positive gastric, GEJ, and esophageal cancers, citing limited benefit in PD-L1-negative patients based on recent trial data.
梅河口市|
乡城县|
当雄县|
叙永县|
永丰县|
友谊县|
灵武市|
衡南县|
同江市|
綦江县|
衡水市|
工布江达县|
洛南县|
柳河县|
阿坝县|
临西县|
新乡市|
淳化县|
建昌县|
隆回县|
临夏市|
丰镇市|
安远县|
贵阳市|
奎屯市|
鞍山市|
泰和县|
崇左市|
富平县|
石柱|
克山县|
台前县|
会东县|
新源县|
鄂托克旗|
宁化县|
奉新县|
原阳县|
张家界市|
宣威市|
红原县|